Table 4 Characteristics of the respondents.

From: Factors of feasibility: an interview study of physicians’ experiences of expanded access to investigational drugs in three countries

Country

The Netherlands (n = 14)

Turkey (n = 9)

United States (n = 13)

Gender—no. (%)

 - Male

8 (57.1)

9 (100)

7 (53.8)

 - Female

6 (42.9)

0 (0.00)

6 (46.2)

Medical specialism—no. (%)

 - Internal medicine

2 (14.3)

0 (0.00)

1 (7.70)

 - Oncology

4 (28.6)

0 (0.00)

3 (23.1)

 - Haematology

3 (21.4)

7 (77.8)

5 (38.5)

 - Psychiatry

2 (14.3)

2 (22.2)

0 (0.00)

 - Neurology/neurosurgery

3 (21.4)

0 (0.00)

3 (23.1)

 - Surgery

0 (0.00)

0 (0.00)

1 (7.70)

Type of hospital—no. (%)

 - Community/public

5 (35.7)

0 (0.0)

4 (30.8)

 - Academic

9 (64.3)

6 (66.7)

8 (61.5)

 - Private

0 (0.00)

3 (33.3)

1 (7.70)

Geographical location of practice—no. (%)

 - The Netherlands

14 (100)

N/a

N/a

 - Istanbul European side

N/a

3 (33.3)

N/a

 - Istanbul Anatolian side

N/a

3 (33.3)

N/a

 - Ankara

N/a

3 (33.3)

N/a

 - New York

N/a

N/a

9 (69.2)

 - Other US cities

N/a

N/a

4 (30.8)

  1. N/a not applicable.